Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPLONTERSEN vs PATISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPLONTERSEN vs PATISIRAN: Safety Overview

Metric EPLONTERSEN PATISIRAN
Total FAERS Reports 250 2,708
Deaths Reported 29 384
Death Rate 11.6% 14.2%
Hospitalizations 61 1,050
Average Patient Age 72.0 yrs 65.6 yrs
% Female Patients 51.5% 34.2%
FDA Approval Date Dec 21, 2023 Aug 10, 2018
Manufacturer AstraZeneca Pharmaceuticals LP Alnylam Pharmaceuticals, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription